1. Skip to Menu
  2. Skip to Content
  3. Skip to Footer>

Snažan napredak u prevenciji raka - Reference

PDFIspisE-mail

Index članka
Snažan napredak u prevenciji raka
Aktivna tvar br. 1: Apigenin
Aktivna tvar br. 2: BITC
Aktivna tvar br. 3: Sulforafan
Zaključak
Reference
Sve stranice

 

Reference:

1. Przegl Lek. 2007;64(10):903-5. 2. Eur J Nutr. 2008 May;47 Suppl 2:73-88.

3. Cancer Lett. 2008 Oct 8;269(2):291-304.

4. Proc Nutr Soc. 2009 Feb;68(1):103-10.

5. Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):184-95.

6. Mol Nutr Food Res. 2009 Feb;53(2):201-16.

7. Oncol Rep. 2009 Jan;21(1):185-92.

8. Mol Cancer Ther. 2006 Nov;5(11):2931-45.

9. Mutat Res. 2004 Nov 2;555(1-2):191-202.

10. Cancer Lett. 2006 Sep 28;241(2):275-80.

11. Expert Rev Anticancer Ther. 2008 Oct;8(10):1611-21.

12. J Chemother. 2008 Feb;20(1):119-25.

13. Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):678-86.

14. Pancreas. 2008 Nov;37(4):426-31.

15. Mol Carcinog. 2008 Nov;47(11):835-44.

16. Int J Oncol. 2008 Oct;33(4):657-63.

17. Int J Oncol. 2009 Sep;35(3):593-9.

18. Am J Clin Nutr. 2009 May;89(5):1553S-7S.

19. Environ Mol Mutagen. 2009 Apr;50(3):238-46.

20. FASEB J. 2005 Mar;19(3):342-53.

21. Carcinogenesis. 2007 Apr;28(4):858-64.

22. Nutr Cancer. 2008;60(6):800-9.

23. FEBS Lett. 2009 Jun 18;583(12):1999-2003.

24. Pancreas. 2007 Nov;35(4):e1-9.

25. Toxicol Appl Pharmacol. 2008 Jan 15;226(2):178-91.

26. J Clin Biochem Nutr. 2009 May;44(3):260-5.

27. Oncol Rep. 2007 Sep;18(3):695-701.

28. Carcinogenesis. 2008 Dec;29(12):2369-76.

29. Int J Cancer. 2009 Apr 15;124(8):1918-25.

30. Forum Nutr. 2009;61:170-81. 31. Mol Cancer Ther. 2005 Aug;4(8):1250-9.

32. J Biol Chem. 2008 Oct 31;283(44):30151-63.

33. J Exp Ther Oncol. 2006;5(4):287-300.

34. J Natl Cancer Inst. 2009 Feb 4;101(3):176-93.

35. Biofactors. 2006;26(2):123-34.

36. J Nutr. 2006 Nov;136(11):2728-34.

37. J Biol Chem. 2008 Aug 8;283(32):22136-46.

38. Nutr Cancer. 2008;60 Suppl 1:12-20.

39. J Biol Chem. 2009 Jun 19;284(25):17039-51.

40. Clin Cancer Res. 2008 Nov 15;14(22):7167-72.

41. Carcinogenesis. 2006 Apr;27(4):782-90.

42. Front Biosci (Elite Ed). 2009;1:568-76.

43. Carcinogenesis. 2009 Jun 23.

44. Carcinogenesis. 2005 Apr;26(4):771-8.

45. Mol Pharmacol. 2006 Feb;69(2):430-9.

46. Oncogene. 2005 Mar 31;24(14):2343-53.

47. Integr Cancer Ther. 2005 Dec;4(4):301-14.

48. Cancer Res. 2007 Apr 1;67(7):3310-9.

49. Carcinogenesis. 2006 Mar;27(3):541-50.

50. Cancer Res. 2008 Mar 15;68(6):1927-34.

51. Biochem Pharmacol. 2008 May 1;75(9):1858-67.

52. J Cell Biochem. 2009 Jun 1;107(3):516-27.

53. Front Biosci. 2005 Jan 1;10:236-43.

54. Mol Cancer Ther. 2007 Oct;6(10):2757-65.

55. Mol Cancer Ther. 2008 Jun;7(6):1708-19.

56. J Cell Physiol. 2009 Apr;219(1):94-9.

57. Zhonghua Yi Xue Za Zhi. 2008 Mar 11;88(10):661-4.

58. Cancer Res. 2009 Jul 1;69(13):5592-600.

59. Clin Cancer Res. 2009 Jan 15;15(2):543-52.

60. Cancer Res. 2009 May 15;69(10):4468-75.

61. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2399-403.

62. Acta Pharmacol Sin. 2007 Sep;28(9):1343-54.

63. Environ Mol Mutagen. 2009 Apr;50(3):213-21.

64. PLoS One. 2008;3(7):e2568.

65. Planta Med. 2008 Oct;74(13):1548-59.

66. Cancer Epidemiol Biomarkers Prev. 2005 Nov;14(11 Pt 1):2605-13.

All Contents Copyright © 1995-2011 Life Extension Foundation All rights reserved.